FactMR, in its latest business intelligence study, depicts the nuts and bolts of the global arthritis therapeutics market. The arthritis therapeutics report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the arthritis therapeutics report elaborates the market behavior of each vendor operating in the arthritis therapeutics market.
On the basis of product, the arthritis therapeutics market study consists of:
- Hoffmann-La Roche Ltd.
- Janssen Global Services, LLC
- Bristol-Myers Squibb Company
- Eli Lilly and Company
Arthritis encompasses around 200 health conditions that affect joints and the tissues in such areas. Osteoarthritis is the most commonly found type of arthritis, and most therapeutics are aimed to combat this condition. Treatments for arthritis are more prevalent across Europe and North America, which can be attributed to the higher level of patient awareness about the condition in comparison to other places around the world. The global arthritis therapeutics market is expected to grow by around 1.5 times through the forecast period till 2027.
The growth can be largely attributed to the growing transition activity from patients from depending on conventional pharmaceuticals to choosing to biologics, as therapy options related to biologics, with the aim of improving patient life substantially. In addition, the industry is witnessing a number of biologics products, which are indicative of superior commercial prospects that are in clinical trials, which are aldo driving developments in the industry.
Europe and North America Dominate Consumption
The arthritis therapeutics market is mostly active around the countries in North America and Europe in comparison to other regions around the globe. This trend can be largely be attributed to the presence of major medical businesses in these region, which are driving a high level of research and development activity in the region.
You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4355
Such activity helps in boosting the availability of drugs, by strengthening production and development networks and widening product portfolios. Further, the addition of biosimilars and biologics to the list of existing arthritis therapeutics, and the rising number of drugs which are due to face patent enquiries are also expected to aid the growth of the market in the region.